LT3347002T - Alzheimerio ligos gydymas tam tikroje pacientų populiacijoje - Google Patents

Alzheimerio ligos gydymas tam tikroje pacientų populiacijoje

Info

Publication number: LT3347002T
Authority: LT; Lithuania
Prior art keywords: alzheimer; disease; treatment; particular patient; patient population
Prior art date: 2015-09-10

Application number

LTEPPCT/US2016/051091T

Other languages

English (en)

Inventor

Susan ABUSHAKRA

Aidan POWER

Martin TOLAR

John Hey

Jeremy Yu

Petr Kocis

Original Assignee

Alzheon, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-09-10

Filing date

2016-09-09

Publication date

2023-09-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58240195&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3347002(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-09-09 Application filed by Alzheon, Inc. filed Critical Alzheon, Inc.

2023-09-11 Publication of LT3347002T publication Critical patent/LT3347002T/lt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Chemical Kinetics & Catalysis (AREA)
Hospice & Palliative Care (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

LTEPPCT/US2016/051091T 2015-09-10 2016-09-09 Alzheimerio ligos gydymas tam tikroje pacientų populiacijoje LT3347002T (lt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US201562216404P	2015-09-10	2015-09-10
US201662290287P	2016-02-02	2016-02-02
US201662302027P	2016-03-01	2016-03-01
US201662365809P	2016-07-22	2016-07-22
PCT/US2016/051091 WO2017044840A1 (en)	2015-09-10	2016-09-09	Methods of treating neurodegenerative disorders in a particular patient population

Publications (1)

Publication Number	Publication Date
LT3347002T true LT3347002T (lt)	2023-09-11

Family

ID=58240195

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEPPCT/US2016/051091T LT3347002T (lt)	2015-09-10	2016-09-09	Alzheimerio ligos gydymas tam tikroje pacientų populiacijoje

Country Status (21)

Country	Link
US (3)	US11191742B2 (lt)
EP (2)	EP3347002B1 (lt)
JP (4)	JP6789579B2 (lt)
KR (2)	KR102412997B1 (lt)
CN (3)	CN116712423A (lt)
AU (1)	AU2016319107B2 (lt)
CA (1)	CA2997376C (lt)
DK (1)	DK3347002T3 (lt)
ES (1)	ES2952727T3 (lt)
FI (1)	FI3347002T3 (lt)
HR (1)	HRP20230809T1 (lt)
HU (1)	HUE062511T2 (lt)
LT (1)	LT3347002T (lt)
MD (1)	MD3347002T2 (lt)
MX (2)	MX392677B (lt)
PL (1)	PL3347002T3 (lt)
PT (1)	PT3347002T (lt)
RS (1)	RS64481B1 (lt)
SI (1)	SI3347002T1 (lt)
SM (1)	SMT202300250T1 (lt)
WO (1)	WO2017044840A1 (lt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR102448386B1 (ko)	2014-03-21	2022-09-28	알제온, 인크.	신경학적 장애를 치료하는 방법
CN116712423A (zh) *	2015-09-10	2023-09-08	阿尔泽恩股份有限公司	治疗特定患者群体的神经变性病症的方法
CN114805211B (zh)	2017-03-21	2024-08-23	润佳（苏州）医药科技有限公司	同位素富集3-氨基-1-丙磺酸衍生物、药物组合物及其用途
CN110003058B (zh)	2018-01-04	2022-01-25	润佳（苏州）医药科技有限公司	3-((l-缬氨酰基)氨基)-3,3-二氘-1-丙磺酸晶型、制备方法及用途
SMT202300443T1 (it) *	2018-08-01	2024-01-10	Alzheon Inc	Derivati di acido solfopropanoico per il trattamento di disturbi neurodegenerativi
BR112021001739A2 (pt) *	2018-08-01	2021-04-27	Alzheon, Inc.	métodos para tratar distúrbios neurodegenerativos
CN111170901A (zh) *	2018-11-13	2020-05-19	润佳（苏州）医药科技有限公司	3-((l-缬氨酰基)氨基)-1-丙磺酸晶型、制备方法及其用途
UA129160C2 (uk) *	2019-06-17	2025-01-29	Алзхеон, Інк.	Спосіб лікування хвороби альцгеймера
CN116059192B (zh)	2019-11-13	2024-10-29	润佳（苏州）医药科技有限公司	同位素富集的3-氨基-1-丙磺酸及其衍生物的用途
EP4444286A1 (en) *	2021-12-09	2024-10-16	Alzheon, Inc.	Alz-801 for use in treating alzheimer's disease
US20250127734A1 (en) *	2022-02-07	2025-04-24	Alzheon, Inc.	Alz-801 for use in treating a covid-19 associated neurological symptom

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5698155A (en)	1991-05-31	1997-12-16	Gs Technologies, Inc.	Method for the manufacture of pharmaceutical cellulose capsules
WO1994009155A1 (en)	1992-10-13	1994-04-28	Duke University	Methods of detecting alzheimer's disease
US20050031651A1 (en)	2002-12-24	2005-02-10	Francine Gervais	Therapeutic formulations for the treatment of beta-amyloid related diseases
US20060079578A1 (en)	2003-06-23	2006-04-13	Julie Laurin	Pharmaceutical formulations of amyloid inhibiting compounds
US20070010573A1 (en)	2003-06-23	2007-01-11	Xianqi Kong	Methods and compositions for treating amyloid-related diseases
US20050142191A1 (en)	2003-06-23	2005-06-30	Neurochem (International) Limited	Pharmaceutical formulations of amyloid inhibiting compounds
JP2007502418A (ja)	2003-08-11	2007-02-08	カリフォルニア・インスティテュート・オブ・テクノロジー	微量流体大規模集積
CA2611586A1 (en) *	2005-04-12	2007-06-21	Neurochem (International) Limited	Pharmaceutical formulations of amyloid inhibiting compounds
ES2533463T3 (es) *	2006-10-12	2015-04-10	Bhi Limited Partnership	Métodos, compuestos, composiciones y vehículos para suministrar ácido 3-amino-1-propanosulfónico
EP2108644B1 (en)	2006-11-24	2016-07-20	AC Immune S.A.	N-(Methyl)-pyridin-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins
JO3076B1 (ar)	2007-10-17	2017-03-15	Janssen Alzheimer Immunotherap	نظم العلاج المناعي المعتمد على حالة apoe
EP2322163A1 (en) *	2009-11-03	2011-05-18	Pharnext	New therapeutics approaches for treating alzheimer disease
US20120009125A1 (en)	2010-07-06	2012-01-12	Lombard Jay L	Apoe4 and apoj biomarker-based prevention and treatment of dementia
JP6250394B2 (ja) *	2010-08-19	2017-12-20	バック・インスティテュート・フォー・リサーチ・オン・エイジング	軽度の認知障害（ｍｃｉ）および関連障害の処置方法
US20150118231A1 (en) *	2012-05-08	2015-04-30	Ramot At Tel-Aviv University Ltd.	Apoe4 antibodies for treatment of neurodegenerative conditions
WO2014182631A1 (en)	2013-05-06	2014-11-13	Baxter International Inc.	Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g
BR112016018170A2 (pt)	2014-02-08	2018-02-20	Genentech, Inc.	métodos para tratar doença de alzheimer
KR102448386B1 (ko) *	2014-03-21	2022-09-28	알제온, 인크.	신경학적 장애를 치료하는 방법
CN116712423A (zh) *	2015-09-10	2023-09-08	阿尔泽恩股份有限公司	治疗特定患者群体的神经变性病症的方法

2016
- 2016-09-09 CN CN202310582394.5A patent/CN116712423A/zh active Pending
- 2016-09-09 WO PCT/US2016/051091 patent/WO2017044840A1/en not_active Ceased
- 2016-09-09 SI SI201631729T patent/SI3347002T1/sl unknown
- 2016-09-09 AU AU2016319107A patent/AU2016319107B2/en active Active
- 2016-09-09 DK DK16845181.3T patent/DK3347002T3/da active
- 2016-09-09 RS RS20230603A patent/RS64481B1/sr unknown
- 2016-09-09 US US15/758,405 patent/US11191742B2/en active Active
- 2016-09-09 KR KR1020187009381A patent/KR102412997B1/ko active Active
- 2016-09-09 CA CA2997376A patent/CA2997376C/en active Active
- 2016-09-09 HU HUE16845181A patent/HUE062511T2/hu unknown
- 2016-09-09 ES ES16845181T patent/ES2952727T3/es active Active
- 2016-09-09 LT LTEPPCT/US2016/051091T patent/LT3347002T/lt unknown
- 2016-09-09 CN CN201680052760.4A patent/CN108289870A/zh active Pending
- 2016-09-09 MX MX2018003023A patent/MX392677B/es unknown
- 2016-09-09 PL PL16845181.3T patent/PL3347002T3/pl unknown
- 2016-09-09 HR HRP20230809TT patent/HRP20230809T1/hr unknown
- 2016-09-09 JP JP2018512564A patent/JP6789579B2/ja active Active
- 2016-09-09 CN CN202310582365.9A patent/CN116712422A/zh active Pending
- 2016-09-09 PT PT168451813T patent/PT3347002T/pt unknown
- 2016-09-09 KR KR1020227009418A patent/KR102547164B1/ko active Active
- 2016-09-09 SM SM20230250T patent/SMT202300250T1/it unknown
- 2016-09-09 MD MDE20180700T patent/MD3347002T2/ro unknown
- 2016-09-09 FI FIEP16845181.3T patent/FI3347002T3/fi active
- 2016-09-09 EP EP16845181.3A patent/EP3347002B1/en active Active
- 2016-09-09 EP EP23176559.5A patent/EP4275750A3/en active Pending
2018
- 2018-03-09 MX MX2022003128A patent/MX2022003128A/es unknown
2020
- 2020-09-28 JP JP2020161995A patent/JP7128536B2/ja active Active
2021
- 2021-09-17 US US17/477,886 patent/US20220096406A1/en not_active Abandoned
2022
- 2022-08-12 JP JP2022128786A patent/JP2022145949A/ja active Pending
2023
- 2023-09-06 US US18/462,238 patent/US20230414541A1/en active Pending
2025
- 2025-02-17 JP JP2025023627A patent/JP2025065545A/ja active Pending

Also Published As

Publication number	Publication date
JP6789579B2 (ja)	2020-11-25
KR102547164B1 (ko)	2023-06-22
KR20220042480A (ko)	2022-04-05
JP7128536B2 (ja)	2022-08-31
JP2020200352A (ja)	2020-12-17
EP4275750A3 (en)	2024-01-17
EP3347002A4 (en)	2019-04-24
PL3347002T3 (pl)	2023-11-13
JP2025065545A (ja)	2025-04-17
MX2022003128A (es)	2022-08-02
PT3347002T (pt)	2023-07-27
KR102412997B1 (ko)	2022-06-23
JP2022145949A (ja)	2022-10-04
AU2016319107A1 (en)	2018-03-22
CN108289870A (zh)	2018-07-17
US20220096406A1 (en)	2022-03-31
EP4275750A2 (en)	2023-11-15
US20230414541A1 (en)	2023-12-28
WO2017044840A1 (en)	2017-03-16
SI3347002T1 (sl)	2023-12-29
SMT202300250T1 (it)	2023-09-06
HK1257874A1 (en)	2019-11-01
CN116712423A (zh)	2023-09-08
ES2952727T3 (es)	2023-11-03
HRP20230809T1 (hr)	2023-10-27
FI3347002T3 (fi)	2023-08-10
AU2016319107B2 (en)	2021-02-25
MD3347002T2 (ro)	2023-10-31
RS64481B1 (sr)	2023-09-29
DK3347002T3 (da)	2023-08-14
EP3347002A1 (en)	2018-07-18
MX2018003023A (es)	2018-06-06
CA2997376C (en)	2024-05-14
CA2997376A1 (en)	2017-03-16
MX392677B (es)	2025-03-24
CN116712422A (zh)	2023-09-08
KR20180051561A (ko)	2018-05-16
EP3347002B1 (en)	2023-06-07
HUE062511T2 (hu)	2023-11-28
US11191742B2 (en)	2021-12-07
JP2018526407A (ja)	2018-09-13

Publication	Publication Date	Title
SMT202300250T1 (it)	2023-09-06	Trattamento della malattia di alzheimer in una particolare popolazione di pazienti
IL247085A0 (en)	2016-09-29	Methods for treating Alzheimer's disease
ZA201605341B (en)	2021-01-27	Methods of treating alzheimer's disease
HUE063369T2 (hu)	2024-01-28	Vegyületek Alzheimer-kór kezelésében történõ alkalmazásra APOE4+/+ betegekben
IL263188B (en)	2021-08-31	Treatment for Parkinson's disease
PL3326637T3 (pl)	2021-10-25	Zastosowanie ekstraktu ze skórki mangostanu w preparatach leczniczych do leczenia chorób skóry
PT3458045T (pt)	2024-10-28	Ebselen para uso no tratamento da doença de ménière
HUE056265T2 (hu)	2022-02-28	Igmezin Alzheimer-kór kezelésében történõ alkalmazásra
PL3137097T3 (pl)	2023-09-11	Leczenie i profilaktyka choroby Alzheimera (AD)
IL254252A0 (en)	2017-10-31	History of Tetrahydrofuran-Oahe Aminohydrothiazine Usefulness in the Treatment of Alzheimer's Disease
PT3137094T (pt)	2023-03-09	Tratamento e prevenção da doença de alzheimer (da)
PT3137093T (pt)	2017-12-19	Tratamento e prevenção da doença de alzheimer (da)
IL263837A (en)	2019-02-03	Treatment of ocular disease
PL3302463T3 (pl)	2020-10-19	Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu
GB201511453D0 (en)	2015-08-12	Treatment of alzheimer's disease
AU2017902309A0 (en)	2017-06-29	Treatment of alzheimer's disease
AU2017902307A0 (en)	2017-06-29	Treatment of alzheimer's disease
GB201518052D0 (en)	2015-11-25	Parkinson's disease treatment
GB201504144D0 (en)	2015-04-22	Treatment of Parkinson's disease
GB201614863D0 (en)	2016-10-19	Alzheimer's disease
GB201610938D0 (en)	2016-08-03	Treatment of ocular disease